» Articles » PMID: 22451099

Cognitive Domains That Predict Time to Diagnosis in Prodromal Huntington Disease

Overview
Date 2012 Mar 28
PMID 22451099
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prodromal Huntington's disease (prHD) is associated with a myriad of cognitive changes but the domains that best predict time to clinical diagnosis have not been studied. This is a notable gap because some domains may be more sensitive to cognitive decline, which would inform clinical trials.

Objectives: The present study sought to characterise cognitive domains underlying a large test battery and for the first time, evaluate their ability to predict time to diagnosis.

Methods: Participants included gene negative and gene positive prHD participants who were enrolled in the PREDICT-HD study. The CAG-age product (CAP) score was the measure of an individual's genetic signature. A factor analysis of 18 tests was performed to identify sets of measures or latent factors that elucidated core constructs of tests. Factor scores were then fit to a survival model to evaluate their ability to predict time to diagnosis.

Results: Six factors were identified: (1) speed/inhibition, (2) verbal working memory, (3) motor planning/speed, (4) attention-information integration, (5) sensory-perceptual processing and (6) verbal learning/memory. Factor scores were sensitive to worsening of cognitive functioning in prHD, typically more so than performances on individual tests comprising the factors. Only the motor planning/speed and sensory-perceptual processing factors predicted time to diagnosis, after controlling for CAP scores and motor symptoms. Conclusions The results suggest that motor planning/speed and sensory-perceptual processing are important markers of disease prognosis. The findings also have implications for using composite indices of cognition in preventive Huntington's disease trials where they may be more sensitive than individual tests.

Citing Articles

Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.

Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani A, Mohamed W Biology (Basel). 2025; 14(2).

PMID: 40001897 PMC: 11852324. DOI: 10.3390/biology14020129.


Feasibility and effects of cognitive training on cognition and psychosocial function in Huntington's disease: a randomised pilot trial.

Huynh K, Jamadar S, Lampit A, Siddiqui M, Stout J, Georgiou-Karistianis N J Neurol. 2025; 272(2):159.

PMID: 39847109 PMC: 11757664. DOI: 10.1007/s00415-024-12855-7.


Effects and mechanisms of computerized cognitive training in Huntington's disease: protocol for a pilot study.

Huynh K, Jamadar S, Stout J, Voigt K, Lampit A, Georgiou-Karistianis N Neurodegener Dis Manag. 2025; 14(6):203-216.

PMID: 39781626 PMC: 11730119. DOI: 10.2217/nmt-2023-0001.


Multivariate longitudinal analysis for the association between brain atrophy and cognitive impairment in prodromal Huntington's disease subjects.

Zheng C, Tong L, Zhang Y J R Stat Soc Ser C Appl Stat. 2024; 73(1):104-122.

PMID: 39280900 PMC: 11393497. DOI: 10.1093/jrsssc/qlad087.


clusterMLD: An Efficient Hierarchical Clustering Method for Multivariate Longitudinal Data.

Zhou J, Zhang Y, Tu W J Comput Graph Stat. 2023; 32(3):1131-1144.

PMID: 37859643 PMC: 10584088. DOI: 10.1080/10618600.2022.2149540.


References
1.
Pirogovsky E, Gilbert P, Jacobson M, Peavy G, Wetter S, Goldstein J . Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease. J Clin Exp Neuropsychol. 2007; 29(4):395-404. DOI: 10.1080/13803390600726829. View

2.
Henley S, Wild E, Hobbs N, Warren J, Frost C, Scahill R . Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia. 2008; 46(8):2152-60. DOI: 10.1016/j.neuropsychologia.2008.02.025. View

3.
Langbehn D, Paulsen J . Predictors of diagnosis in Huntington disease. Neurology. 2007; 68(20):1710-7. DOI: 10.1212/01.wnl.0000261918.90053.96. View

4.
Paulsen J, Zimbelman J, Hinton S, Langbehn D, Leveroni C, Benjamin M . fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am J Neuroradiol. 2004; 25(10):1715-21. PMC: 8148746. View

5.
Warner J, Barron L, Brock D . A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes. 1993; 7(3):235-9. DOI: 10.1006/mcpr.1993.1034. View